Stallion India Fluorochemicals Limited has announced its financial results for the fiscal year 2026, reporting a robust 35.61% year-on-year growth in profit after tax (PAT). The company's resilient performance comes despite a challenging macroeconomic environment, driven by strong operational efficiencies and strategic market positioning.
Key Financial Highlights
The company's PAT for FY26 stood at INR 45.2 crore, compared to INR 33.3 crore in the previous fiscal year. Revenue from operations increased by 18.4% to INR 520 crore, up from INR 439 crore in FY25. The earnings before interest, taxes, depreciation, and amortization (EBITDA) margin improved to 14.2%, reflecting better cost management and higher capacity utilization.
Segment Performance
The fluorochemicals segment, which accounts for the majority of the company's revenue, saw a 20% growth in sales volume. This was primarily driven by increased demand from the pharmaceutical and agrochemical industries. The company's specialty chemicals division also performed well, with a 15% rise in revenue, supported by new product launches and expanded distribution networks.
Operational Efficiency
Stallion India Fluorochemicals continued to focus on operational excellence, resulting in a reduction of manufacturing costs by 5% year-on-year. The company's plant utilization rate reached 85%, up from 78% in the previous year, contributing to higher margins. Additionally, the company invested INR 30 crore in capacity expansion and technology upgrades during the year.
Management Commentary
Commenting on the results, the Managing Director of Stallion India Fluorochemicals stated, 'We are pleased with our FY26 performance, which reflects the resilience of our business model and the dedication of our team. Despite global uncertainties, we achieved strong growth in both revenue and profitability. Our focus on innovation and customer-centric solutions has enabled us to capture new opportunities and strengthen our market position.'
Future Outlook
Looking ahead, the company remains optimistic about the demand for fluorochemicals, particularly in the healthcare and agriculture sectors. Stallion India Fluorochemicals plans to further expand its product portfolio and explore new markets to sustain growth momentum. The company also aims to enhance its sustainability initiatives by reducing carbon emissions and improving waste management practices.
Financial Summary
- Revenue from Operations: INR 520 crore (up 18.4% YoY)
- Profit After Tax: INR 45.2 crore (up 35.61% YoY)
- EBITDA Margin: 14.2% (improved from 12.8% in FY25)
- Basic EPS: INR 12.50 (up from INR 9.20 in FY25)
The company's board has recommended a final dividend of INR 2 per share, subject to shareholder approval. The results were announced after market hours on March 27, 2025.
